DOUG · Douglas Elliman Inc. · Insider Trading

On August 14, 2026 the Issuer granted the Reporting Person a restricted stock award of 74,627 shares of Issuer Common Stock pursuant to Issuer's 2021 Management Incentive Plan. The award will vest on August 14, 2027, subject to the Reporting Person's continued service through such vesting date or earlier vesting upon the Reporting Person's death or disability or a change-of-control.

On August 14, 2026 the Issuer granted the Reporting Person a restricted stock award of 74,627 shares of Issuer Common Stock pursuant to Issuer's 2021 Management Incentive Plan. The award will vest on August 14, 2027, subject to the Reporting Person's continued service through such vesting date or earlier vesting upon the Reporting Person's death or disability or a change-of-control.

Represents withholdings of shares as payment of the Reporting Person's payroll tax liabilities incident to the vesting of an aggregate of 62,500 shares of restricted stock, which were awarded to Reporting Person on August 13, 2025. The shares withheld were valued at $2.0075 per share, which represented the average of the low ($1.95) and high ($2.065) stock prices of the Issuer's Common Stock on August 13, 2026, the date of vesting.

On April 10, 2026, the Issuer granted the Reporting Person a restricted stock award of 1,000,000 shares of Issuer Common Stock pursuant to Issuer's 2021 Management Incentive Plan. The award will vest in three equal annual installments commencing on December 15, 2026, subject to the Reporting Person's continued employment through each such vesting date or earlier vesting upon a change-of-control as well as, in the event of termination without cause or for good reason, an accelerated vesting of the next tranche, if applicable.

On April 10, 2026 the Issuer granted the Reporting Person a restricted stock award of 90,910 shares of Issuer Common Stock pursuant to Issuer's 2021 Management Incentive Plan. The award will vest on April 10, 2027, subject to the Reporting Person's continued service through such vesting date or earlier vesting upon the Reporting Person's death or disability or a change-of-control.

On April 10, 2026 the Issuer granted the Reporting Person a restricted stock award of 90,910 shares of Issuer Common Stock pursuant to Issuer's 2021 Management Incentive Plan. The award will vest on April 10, 2027, subject to the Reporting Person's continued service through such vesting date or earlier vesting upon the Reporting Person's death or disability or a change-of-control.

On April 10, 2026 the Issuer granted the Reporting Person a restricted stock award of 90,910 shares of Issuer Common Stock pursuant to Issuer's 2021 Management Incentive Plan. The award will vest on April 10, 2027, subject to the Reporting Person's continued service through such vesting date or earlier vesting upon the Reporting Person's death or disability or a change-of-control.

On April 10, 2026 the Issuer granted the Reporting Person a restricted stock award of 90,910 shares of Issuer Common Stock pursuant to Issuer's 2021 Management Incentive Plan. The award will vest on April 10, 2027, subject to the Reporting Person's continued service through such vesting date or earlier vesting upon the Reporting Person's death or disability or a change-of-control.

On April 10, 2026, the Issuer granted the Reporting Person a restricted stock award of 175,000 shares of Issuer Common Stock pursuant to Issuer's 2021 Management Incentive Plan. The award will vest in three equal annual installments commencing on December 15, 2026, subject to the Reporting Person's continued employment through each such vesting date or earlier vesting upon a change-of-control as well as, in the event of termination without cause or for good reason, accelerated vesting of the next tranche, if applicable.

On April 10, 2026, the Issuer granted the Reporting Person a restricted stock award of 1,250,000 shares of Issuer Common Stock pursuant to Issuer's 2021 Management Incentive Plan. The award will vest in three equal annual installments commencing on December 15, 2026, subject to the Reporting Person's continued employment through each such vesting date or earlier vesting upon a change-of-control as well as, in the event of termination without cause or for good reason, an accelerated vesting of the next tranche, if applicable.

Includes the transfer of 303,250 shares previously held directly by the Reporting Person to MSL18 Holdings LLC.

Represents withholdings of shares as payment of the Reporting Person's payroll tax liabilities incident to the vesting of an aggregate of 38,750 shares of restricted stock, which were awarded to Reporting Person on December 31, 2021, March 14, 2023 and February 29, 2024. The shares withheld were valued at $2.755 per share, which represented the average of the low ($2.66) and high ($2.85) stock prices of the Issuer's Common Stock on December 15, 2025, the date of vesting.

Represents withholdings of shares as payment of the Reporting Person's payroll tax liabilities incident to the vesting of an aggregate of 25,625 shares of restricted stock, which were awarded to Reporting Person on January 1, 2023 and February 29, 2024. The shares withheld were valued at $2.755 per share, which represented the average of the low ($2.66) and high ($2.85) stock prices of the Issuer's Common Stock on December 15, 2025, the date of vesting.

Represents withholdings of shares as payment of the Reporting Person's payroll tax liabilities incident to the vesting of an aggregate of 191,250 shares of restricted stock, which were awarded to Reporting Person on December 31, 2021, March 14, 2023, February 29, 2024 and October 30, 2024. The shares withheld were valued at $2.755 per share, which represented the average of the low ($2.66) and high ($2.85) stock prices of the Issuer's Common Stock on December 15, 2025, the date of vesting.

On November 26, 2025 the Issuer granted the Reporting Person a restricted stock award of 58,594 shares of Issuer Common Stock pursuant to Issuer's 2021 Management Incentive Plan. The award will vest in two equal annual installments on each of November 26, 2026 and November 26, 2027, subject to the Reporting Person's continued service through each such vesting date or earlier vesting upon the Reporting Person's death or disability or a change-of-control.

Represents withholdings of shares as payment of the Reporting Person's payroll tax liabilities incident to the vesting of an aggregate of 500,000 shares of restricted stock, which were awarded to the Reporting Person on November 24, 2024. The shares withheld were valued at $2.41 per share, which represented the average of the low ($2.35) and high ($2.47) stock prices of the Issuer's Common Stock on November 24, 2025, the date of vesting.

Reflects the transfer of 56,530 shares previously held directly by the Reporting Person to MSL18 Holdings LLC.

The Funds had the right to elect at any time to convert their respective Convertible Notes into shares of common stock, par value $0.01 per share ("Common Stock"), of the Issuer at an initial conversion price equal to $1.50 per share of Common Stock, subject to adjustment as set forth in the Convertible Notes, so long as the aggregate number of shares of Common Stock beneficially owned by such Fund, together with its affiliates and any member of a Section 13(d) group with such Fund or any of its affiliates, would not exceed 4.99% of the number of shares of Common Stock outstanding immediately after giving effect to the conversion (the "Beneficial Ownership Limitation").

(Continued from footnote 8) The Funds had the right to increase or decrease the Beneficial Ownership Limitation upon no less than 61 days' prior written notice to the Issuer, provided that the Beneficial Ownership Limitation could in no event exceed 24.99% of the number of shares of Common Stock outstanding immediately after giving effect to the conversion. The conversion price was subject to certain customary anti-dilution adjustments.

On October 24, 2025, in connection with the sale by an indirect subsidiary of Douglas Elliman Inc. (the "Issuer") of the equity interests it held in another indirect subsidiary of the Issuer to a third party, the Issuer repurchased the previously reported Senior Secured Convertible Promissory Notes (collectively, the "Convertible Notes") held by KLCP Fund III (EU) Master AIV LP ("KLCP Fund III") and KLIM Delta HQC3 LP ("KLIM Delta", and together with KLCP Fund III, the "Funds") for an aggregate purchase price of $95,000,000. In connection with the repurchase of the Convertible Notes, on October 24, 2025, David Chene, a Manager of Kennedy Lewis Investment Holdings II LLC ("Holdings II"), resigned from the Issuer's Board of Directors.

This Convertible Note between KLIM Delta and the Issuer was due July 2, 2029, had a principal amount of $4,209,890.99 and bore interest at a rate of 7.0% per annum payable in cash, or, if no Event of Default (as defined in such Convertible Note) had occurred or was continuing, at the Issuer's election, 8.0% per annum paid in kind, due semi-annually. The maturity date of this Convertible Note was July 2, 2029.

These securities were held by KLIM Delta.

Kennedy Lewis GP III LLC ("Kennedy Lewis GP III") is the general partner of each of the Funds. Holdings II is the managing member of Kennedy Lewis GP III. Holdings II is controlled by its board of managers. David Chene and Darren Richman, each a Manager of Holdings II, are the effective control persons of Holdings II. Each of Kennedy Lewis GP III, Holdings II, David Chene and Darren Richman may have been deemed to exercise voting and investment power over and thus may have been deemed to have beneficially owned the securities reported herein that were held by the Funds due to their relationship with the Funds.

For purposes of Section 16 of the Securities Exchange Act of 1934, each of Kennedy Lewis GP III, Holdings II, David Chene and Darren Richman disclaims beneficial ownership of the securities of the Issuer reported herein that were held directly by the Funds except to the extent of its or his pecuniary interest therein, and this report shall not be deemed an admission that any of Kennedy Lewis GP III, Holdings II, David Chene or Darren Richman was the beneficial owner of such securities for purposes of Section 16 or any other purpose.

The Funds had the right to elect at any time to convert their respective Convertible Notes into shares of common stock, par value $0.01 per share ("Common Stock"), of the Issuer at an initial conversion price equal to $1.50 per share of Common Stock, subject to adjustment as set forth in the Convertible Notes, so long as the aggregate number of shares of Common Stock beneficially owned by such Fund, together with its affiliates and any member of a Section 13(d) group with such Fund or any of its affiliates, would not exceed 4.99% of the number of shares of Common Stock outstanding immediately after giving effect to the conversion (the "Beneficial Ownership Limitation").

(Continued from footnote 8) The Funds had the right to increase or decrease the Beneficial Ownership Limitation upon no less than 61 days' prior written notice to the Issuer, provided that the Beneficial Ownership Limitation could in no event exceed 24.99% of the number of shares of Common Stock outstanding immediately after giving effect to the conversion. The conversion price was subject to certain customary anti-dilution adjustments.

On October 24, 2025, in connection with the sale by an indirect subsidiary of Douglas Elliman Inc. (the "Issuer") of the equity interests it held in another indirect subsidiary of the Issuer to a third party, the Issuer repurchased the previously reported Senior Secured Convertible Promissory Notes (collectively, the "Convertible Notes") held by KLCP Fund III (EU) Master AIV LP ("KLCP Fund III") and KLIM Delta HQC3 LP ("KLIM Delta", and together with KLCP Fund III, the "Funds") for an aggregate purchase price of $95,000,000. In connection with the repurchase of the Convertible Notes, on October 24, 2025, David Chene, a Manager of Kennedy Lewis Investment Holdings II LLC ("Holdings II"), resigned from the Issuer's Board of Directors.

This Convertible Note between KLCP Fund III and the Issuer was due July 2, 2029, had a principal amount of $45,790,109.01 and bore interest at a rate of 7.0% per annum payable in cash, or, if no Event of Default (as defined in such Convertible Note) had occurred or was continuing, at the Issuer's election, 8.0% per annum paid in kind, due semi-annually. The maturity date of this Convertible Note was July 2, 2029.

These securities were held by KLCP Fund III.

Kennedy Lewis GP III LLC ("Kennedy Lewis GP III") is the general partner of each of the Funds. Holdings II is the managing member of Kennedy Lewis GP III. Holdings II is controlled by its board of managers. David Chene and Darren Richman, each a Manager of Holdings II, are the effective control persons of Holdings II. Each of Kennedy Lewis GP III, Holdings II, David Chene and Darren Richman may have been deemed to exercise voting and investment power over and thus may have been deemed to have beneficially owned the securities reported herein that were held by the Funds due to their relationship with the Funds.

For purposes of Section 16 of the Securities Exchange Act of 1934, each of Kennedy Lewis GP III, Holdings II, David Chene and Darren Richman disclaims beneficial ownership of the securities of the Issuer reported herein that were held directly by the Funds except to the extent of its or his pecuniary interest therein, and this report shall not be deemed an admission that any of Kennedy Lewis GP III, Holdings II, David Chene or Darren Richman was the beneficial owner of such securities for purposes of Section 16 or any other purpose.

On August 13, 2025, the Issuer granted the Reporting Person a restricted stock award of 250,000 shares of Issuer Common Stock pursuant to Issuer's 2021 Management Incentive Plan. The award will vest in four equal annual installments commencing on August 13, 2026, subject to the Reporting Person's continued employment through each such vesting date or earlier vesting upon a change-of-control as well as, in the event of termination without cause or for good reason, accelerated vesting of the next two tranches, if applicable.

On June 28, 2025 the Issuer granted the Reporting Person a restricted stock award of 61,983 shares of Issuer Common Stock pursuant to Issuer's 2021 Management Incentive Plan. The award will vest in two equal annual installments on each of June 28, 2026 and June 28, 2027, subject to the Reporting Person's continued service through each such vesting date or earlier vesting upon the Reporting Person's death or disability or a change-of-control.

On June 28, 2025, Douglas Elliman Inc. (the "Issuer") granted 61,983 shares of restricted Common Stock to David Chene, a member of the Issuer's Board of Directors (the "Board") in respect of his service on the Board. Mr. Chene holds the shares of restricted Common Stock for the benefit of KLIM Delta HQC3 LP ("KLIM Delta") and KLCP Fund III (EU) Master AIV LP ("KLCP Fund III", and together with KLIM Delta, the "Funds"). Because Mr. Chene serves on the Board as a representative of the Funds and their affiliates, Mr. Chene does not have a right to any economic interest in securities of the Issuer granted to him by the Issuer in respect of his Board position and the Funds are entitled to an indirect proportionate pecuniary interest in any securities granted to Mr. Chene by the Issuer in respect of Mr. Chene's Board position.

(Continued from footnote 1) Mr. Chene disclaims any direct beneficial ownership of the Issuer's securities to which this report relates and at no time has Mr. Chene had any economic interest in such securities except any indirect economic interest through interests in the Funds and their affiliates. The restricted stock award was granted under the Issuer's 2021 Management Incentive Plan, and vests in two equal annual installments on each of June 28, 2026 and June 28, 2027, subject to Mr. Chene's continued service through each such vesting date or earlier vesting upon Mr. Chene's death or disability or a change-of-control.

The 61,983 shares of restricted Common Stock are reported for each of the Funds as each has an indirect pecuniary interest.

As described in footnotes (1) and (2), the reported securities represent shares of restricted Common Stock in which KLIM Delta may be deemed to have an indirect proportionate pecuniary interest.

Kennedy Lewis GP III LLC ("Kennedy Lewis GP III") is the general partner of each of the Funds. Kennedy Lewis Investment Holdings II LLC ("Holdings II") is the managing member of Kennedy Lewis GP III. Holdings II is controlled by its board of managers. David Chene and Darren Richman, each a Manager of Holdings II, are the effective control persons of Holdings II. Each of Kennedy Lewis GP III, Holdings II, David Chene and Darren Richman may be deemed to exercise voting and investment power over and thus may be deemed to beneficially own the securities held by the Funds due to their relationship with the Funds.

For purposes of Section 16 of the Securities Exchange Act of 1934, each of Kennedy Lewis GP III, Holdings II, David Chene and Darren Richman disclaims beneficial ownership of the securities of the Issuer held directly by the Funds except to the extent of its or his pecuniary interest therein, and this report shall not be deemed an admission that any of Kennedy Lewis GP III, Holdings II, David Chene or Darren Richman is the beneficial owner of such securities for purposes of Section 16 or any other purpose.

On June 28, 2025 the Issuer granted the Reporting Person a restricted stock award of 61,983 shares of Issuer Common Stock pursuant to Issuer's 2021 Management Incentive Plan. The award will vest in two equal annual installments on each of June 28, 2026 and June 28, 2027, subject to the Reporting Person's continued service through each such vesting date or earlier vesting upon the Reporting Person's death or disability or a change-of-control.

On June 28, 2025 the Issuer granted the Reporting Person a restricted stock award of 61,983 shares of Issuer Common Stock pursuant to Issuer's 2021 Management Incentive Plan. The award will vest in two equal annual installments on each of June 28, 2026 and June 28, 2027, subject to the Reporting Person's continued service through each such vesting date or earlier vesting upon the Reporting Person's death or disability or a change-of-control.

On June 28, 2025, Douglas Elliman Inc. (the "Issuer") granted 61,983 shares of restricted Common Stock to David Chene, a member of the Issuer's Board of Directors (the "Board") in respect of his service on the Board. Mr. Chene holds the shares of restricted Common Stock for the benefit of KLIM Delta HQC3 LP ("KLIM Delta") and KLCP Fund III (EU) Master AIV LP ("KLCP Fund III", and together with KLIM Delta, the "Funds"). Because Mr. Chene serves on the Board as a representative of the Funds and their affiliates, Mr. Chene does not have a right to any economic interest in securities of the Issuer granted to him by the Issuer in respect of his Board position and the Funds are entitled to an indirect proportionate pecuniary interest in any securities granted to Mr. Chene by the Issuer in respect of Mr. Chene's Board position.

(Continued from footnote 1) Mr. Chene disclaims any direct beneficial ownership of the Issuer's securities to which this report relates and at no time has Mr. Chene had any economic interest in such securities except any indirect economic interest through interests in the Funds and their affiliates. The restricted stock award was granted under the Issuer's 2021 Management Incentive Plan, and vests in two equal annual installments on each of June 28, 2026 and June 28, 2027, subject to Mr. Chene's continued service through each such vesting date or earlier vesting upon Mr. Chene's death or disability or a change-of-control.

The 61,983 shares of restricted Common Stock are reported for each of the Funds as each has an indirect pecuniary interest.

As described in footnotes (1) and (2), the reported securities represent shares of restricted Common Stock in which KLCP Fund III may be deemed to have an indirect proportionate pecuniary interest.

Kennedy Lewis GP III LLC ("Kennedy Lewis GP III") is the general partner of each of the Funds. Kennedy Lewis Investment Holdings II LLC ("Holdings II") is the managing member of Kennedy Lewis GP III. Holdings II is controlled by its board of managers. David Chene and Darren Richman, each a Manager of Holdings II, are the effective control persons of Holdings II. Each of Kennedy Lewis GP III, Holdings II, David Chene and Darren Richman may be deemed to exercise voting and investment power over and thus may be deemed to beneficially own the securities held by the Funds due to their relationship with the Funds.

For purposes of Section 16 of the Securities Exchange Act of 1934, each of Kennedy Lewis GP III, Holdings II, David Chene and Darren Richman disclaims beneficial ownership of the securities of the Issuer held directly by the Funds except to the extent of its or his pecuniary interest therein, and this report shall not be deemed an admission that any of Kennedy Lewis GP III, Holdings II, David Chene or Darren Richman is the beneficial owner of such securities for purposes of Section 16 or any other purpose.

On June 28, 2025 the Issuer granted the Reporting Person a restricted stock award of 61,983 shares of Issuer Common Stock pursuant to Issuer's 2021 Management Incentive Plan. The award will vest in two equal annual installments on each of June 28, 2026 and June 28, 2027, subject to the Reporting Person's continued service through each such vesting date or earlier vesting upon the Reporting Person's death or disability or a change-of-control.

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.86 to $1.95, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.82 to $1.89, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.83 to $1.86, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Represents withholdings of shares as payment of the Reporting Person's payroll tax liabilities incident to the vesting of an aggregate of 38,750 shares of restricted stock, which were awarded to reporting person on December 31, 2021, March 14, 2023 and February 29, 2024. The shares withheld were valued at $2.0125 per share, which represented the average of the low ($1.965) and high ($2.06) stock prices of the Issuer's Common Stock on December 13, 2024, the last trading day before the date of vesting.

Represents withholdings of shares as payment of the Reporting Person's payroll tax liabilities incident to the vesting of an aggregate of 25,625 shares of restricted stock, which were awarded to reporting person on December 31, 2021, March 14, 2023 and February 29, 2024. The shares withheld were valued at $2.0125 per share, which represented the average of the low ($1.965) and high ($2.06) stock prices of the Issuer's Common Stock on December 13, 2024, the last trading date before date of vesting.

Represents withholdings of shares as payment of the Reporting Person's payroll tax liabilities incident to the vesting of an aggregate of 191,250 shares of restricted stock, which were awarded to reporting person on December 31, 2021, March 14, 2023, February 29, 2024 and October 30, 2024. The shares withheld were valued at $2.0125 per share, which represented the average of the low ($2.06) and high ($1.965) stock prices of the Issuer's Common Stock on December 13, 2024, the last trading day before the date of vesting.

Represents withholdings of shares as payment of the Reporting Person's payroll tax liabilities incident to the vesting of an aggregate of 31,000 shares of restricted stock, which were awarded to reporting person on December 31, 2021, March 14, 2023 and February 29, 2024. The shares withheld were valued at $2.0125 per share, which represented the average of the low ($1.965) and high ($2.06) stock prices of the Issuer's Common Stock on December 13, 2024, the last trading date before the date of vesting.

As a result of the decision of the Reporting Person, who is age 71, to retire voluntarily as an employee of the Issuer on December 13, 2024, the Reporting Person's unvested stock awards were cancelled in accordance with their terms. The Reporting Person will continue to serve as a member of the Board of Directors of the Issuer and any future stock awards to the Reporting Person will be made under the Issuer's program of stock compensation to non-employee directors.

On December 4, 2024 the Issuer granted the Reporting Person a restricted stock award of 46,273 shares of Issuer Common Stock pursuant to Issuer's 2021 Management Incentive Plan. The award will vest in two equal annual installments on each of December 4, 2025 and December 4, 2026, subject to the Reporting Person's continued service through each such vesting date or earlier vesting upon the Reporting Person's death or disability or a change-of-control.

On November 24, 2024, the Issuer granted the Reporting Person a restricted stock award of 1,500,000 shares of Issuer Common Stock pursuant to Issuer's 2021 Management Incentive Plan. The award will vest in three equal annual installments commencing on November 24, 2025, subject to the Reporting Person's continued employment through each such vesting date or earlier vesting upon a change-of-control.

On November 24, 2024, the Issuer granted the Reporting Person a Performance Share Unit Grant that provides for a three-year performance period commencing as of January 1, 2025 (the "Performance Period"), with the number of shares of Common Stock to be issued as soon as practicable following the end of the Performance Period determined as follows (the "Performance Thresholds"): (A) if the 30-day volume weighted average share price of the Common Stock at the end of the Performance Period (the "Performance Stock Price") is less than $3.00, no Common Stock will be issued in settlement of the PSUs, and the PSUs shall be forfeited in their entirety; (B) if the Performance Stock Price is equal to $3.00, 775,000 shares of Common Stock will be issued as full settlement of the PSUs; (C) if the Performance Stock Price is equal to $4.00,

(Continued from footnote 3) 1,550,000 shares of Common Stock will be issued as full settlement of the PSUs; and (D) if the Performance Stock Price is equal to or greater than $5.00, 2,325,000 shares of Common Stock will be issued as full settlement of the PSUs; provided that, in each case, the shares of Common Stock to be issued in settlement of the PSUs described above will be determined where the Performance Stock Price is more than $3.00 and less than $5.00 (and is not $4.00) by a linear extrapolation between the per share Common Stock value between $3.00 and $4.00, or between $4.00 and $5.00, as the case may be. Subject to the terms of the Performance Share Unit Grant, it shall cease vesting if Reporting Person resigns or is terminated for Cause (as defined in the Reporting Person's Employment Agreement). In addition, upon the consummation of a Change of Control (as defined in the Reporting Person's Employment Agreement),

(Continued from footnote 3) the Performance Period shall accelerate and deemed complete upon the date of the Change of Control. Further, the Reporting Person shall be entitled, under the Performance Share Unit Grant, to a pro rata portion of the applicable Performance Threshold based on the Performance Stock Price at the time of the Reporting Person's termination without Cause, such that (x) to the extent the Reporting Person is terminated prior to January 1, 2026, the Reporting Person shall not be entitled to any accelerated vesting under the Performance Share Unit Grant, (y) to the extent Reporting Person is terminated after January 1, 2026 but prior to December 31, 2026, the Reporting Person shall be entitled to one-third of the applicable Performance Threshold and (z) to the extent the Reporting Person is terminated after January 1, 2027 but prior to December 31, 2027, the Reporting Person shall be entitled to two-thirds of the applicable Performance Threshold.

On November 18, 2024, the Reporting Person, through MSL18 Holdings LLC, a single member LLC owned by the Reporting Person, purchased 1,081,414 shares from the Issuer's former Chairman, President and Chief Executive Officer for $1.68 per share in a privately negotiated transaction.

MSL18 Holdings LLC is a single member LLC owned by Reporting Person.

The reporting person's sale of Douglas Elliman common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 100,000 shares, with the reporting person's purchases of: (1) 15,238 shares of Douglas Elliman common stock at a weighted average price of $1.09 per share on July 8, 2024; (2) 82,067 shares of Douglas Elliman common stock at a weighted average price of $1.15 per share on July 9, 2024; and (3) 2,605 shares of Douglas Elliman common stock at a weighted average price of $1.23 per share on July 10, 2024. The reporting person has paid to Douglas Elliman $51,426.58, representing the full amount of the profit realized in connection with the short-swing transaction, less transaction costs.

Total amount reported reflects the cancellation of 2,965,625 unvested shares of Douglas Elliman common stock subject to vesting on October 21, 2024 in connection with the reporting person's cessation of employment with Douglas Elliman.

On October 30, 2024, the Issuer granted the Reporting Person a restricted stock award of 300,000 shares of Issuer Common Stock pursuant to Issuer's 2021 Management Incentive Plan. The award will vest in four equal annual installments commencing on December 15, 2024, subject to the Reporting Person's continued employment through each such vesting date or earlier vesting upon a change-of-control

On July 31, 2024, Douglas Elliman Inc. (the "Issuer") granted 58,975 shares of restricted Common Stock to David Chene, a member of the Issuer's Board of Directors (the "Board") in respect of his service on the Board. Mr. Chene holds the shares of restricted Common Stock for the benefit of KLIM Delta HQC3 LP ("KLIM Delta") and KLCP Fund III (EU) Master AIV LP ("KLCP Fund III", and together with KLIM Delta, the "Funds"). Because Mr. Chene serves on the Board as a representative of the Funds and their affiliates, Mr. Chene does not have a right to any economic interest in securities of the Issuer granted to him by the Issuer in respect of his Board position and the Funds are entitled to an indirect proportionate pecuniary interest in any securities granted to Mr. Chene by the Issuer in respect of Mr. Chene's Board position.

(Continued from Footnote 1) Mr. Chene disclaims any direct beneficial ownership of the Issuer's securities to which this report relates and at no time has Mr. Chene had any economic interest in such securities except any indirect economic interest through interests in the Funds and their affiliates. The restricted stock award was granted under the Issuer's 2021 Management Incentive Plan, and vests in two equal annual installments on each of July 31, 2025 and July 31, 2026, subject to Mr. Chene's continued service through each such vesting date or earlier vesting upon Mr. Chene's death or disability or a change-of-control.

The 58,975 shares of restricted Common Stock are reported for each of the Funds as each has an indirect pecuniary interest.

As described in footnotes (1), (2) and (3), the reported securities represent shares of restricted Common Stock in which KLCP Fund III may be deemed to have an indirect proportionate pecuniary interest.

Kennedy Lewis GP III LLC ("Kennedy Lewis GP III") is the general partner of each of the Funds. Kennedy Lewis Investment Holdings II LLC ("Holdings II") is the managing member of Kennedy Lewis GP III. Holdings II is controlled by its board of managers. David Chene and Darren Richman, each a Manager of Holdings II, are the effective control persons of Holdings II. Each of Kennedy Lewis GP III, Holdings II, David Chene and Darren Richman may be deemed to exercise voting and investment power over and thus may be deemed to beneficially own the securities held by the Funds due to their relationship with the Funds.

For purposes of Section 16 of the Securities Exchange Act of 1934, each of Kennedy Lewis GP III, Holdings II, David Chene and Darren Richman disclaims beneficial ownership of the securities of the Issuer held directly by the Funds except to the extent of its or his pecuniary interest therein, and this report shall not be deemed an admission that any of Kennedy Lewis GP III, Holdings II, David Chene or Darren Richman is the beneficial owner of such securities for purposes of Section 16 or any other purpose.

On July 31, 2024 the Issuer granted the Reporting Person a restricted stock award of 58,975 shares of Issuer Common Stock pursuant to Issuer's 2021 Management Incentive Plan. The award will vest in two equal annual installments on each of July 31, 2025 and July 31, 2026, subject to the Reporting Person's continued service through each such vesting date or earlier vesting upon the Reporting Person's death or disability or a change-of-control.

On July 31, 2024, Douglas Elliman Inc. (the "Issuer") granted 58,975 shares of restricted Common Stock to David Chene, a member of the Issuer's Board of Directors (the "Board") in respect of his service on the Board. Mr. Chene holds the shares of restricted Common Stock for the benefit of KLIM Delta HQC3 LP ("KLIM Delta") and KLCP Fund III (EU) Master AIV LP ("KLCP Fund III", and together with KLIM Delta, the "Funds"). Because Mr. Chene serves on the Board as a representative of the Funds and their affiliates, Mr. Chene does not have a right to any economic interest in securities of the Issuer granted to him by the Issuer in respect of his Board position and the Funds are entitled to an indirect proportionate pecuniary interest in any securities granted to Mr. Chene by the Issuer in respect of Mr. Chene's Board position.

(Continued from Footnote 1) Mr. Chene disclaims any direct beneficial ownership of the Issuer's securities to which this report relates and at no time has Mr. Chene had any economic interest in such securities except any indirect economic interest through interests in the Funds and their affiliates. The restricted stock award was granted under the Issuer's 2021 Management Incentive Plan, and vests in two equal annual installments on each of July 31, 2025 and July 31, 2026, subject to Mr. Chene's continued service through each such vesting date or earlier vesting upon Mr. Chene's death or disability or a change-of-control.

The 58,975 shares of restricted Common Stock are reported for each of the Funds as each has an indirect pecuniary interest.

As described in footnotes (1), (2) and (3), the reported securities represent shares of restricted Common Stock in which KLIM Delta may be deemed to have an indirect proportionate pecuniary interest.

Kennedy Lewis GP III LLC ("Kennedy Lewis GP III") is the general partner of each of the Funds. Kennedy Lewis Investment Holdings II LLC ("Holdings II") is the managing member of Kennedy Lewis GP III. Holdings II is controlled by its board of managers. David Chene and Darren Richman, each a Manager of Holdings II, are the effective control persons of Holdings II. Each of Kennedy Lewis GP III, Holdings II, David Chene and Darren Richman may be deemed to exercise voting and investment power over and thus may be deemed to beneficially own the securities held by the Funds due to their relationship with the Funds.

For purposes of Section 16 of the Securities Exchange Act of 1934, each of Kennedy Lewis GP III, Holdings II, David Chene and Darren Richman disclaims beneficial ownership of the securities of the Issuer held directly by the Funds except to the extent of its or his pecuniary interest therein, and this report shall not be deemed an admission that any of Kennedy Lewis GP III, Holdings II, David Chene or Darren Richman is the beneficial owner of such securities for purposes of Section 16 or any other purpose.

MSL18 Holdings LLC is a single member LLC owned by Reporting Person.

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.175 to $1.23, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.225 to $1.23, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.175 to $1.18, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.14 to $1.16, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.13 to $1.17, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.135 to $1.18, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.07 to $1.12, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.095 to $1.10, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.